Literature DB >> 11310207

Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia.

A Ogose1, T Hotta, I Emura, H Hatano, Y Inoue, H Umezu, N Endo.   

Abstract

Phosphaturic mesenchymal tumor is a rare neoplasm which causes osteomalacia or rickets. The tumor typically follows a benign clinical course. Even in the rare malignant cases, local recurrence and distant metastasis are uncommon. We report on an example of a malignant phosphaturic mesenchymal tumor which recurred several times over 16 years concurrently causing hypophosphatemia, bone pain, and osteomalacia. Following each surgery, symptoms and hypophosphatemia improved. The patient died of disease 17 years after the first surgery. Histologically, the initial tumor was composed of small spindle cells with clusters of giant cells, prominent blood vessels, poorly formed cartilaginous areas, and crystalline material. Cytological atypia was minimal. Following multiple recurrences, the tumor demonstrated areas of high-grade sarcoma exhibiting marked pleomorphism, numerous mitotic figures, and p53 overexpression. This case illustrates the potential lethality of incompletely removed phosphaturic mesenchymal tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11310207     DOI: 10.1007/s002560000306

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  29 in total

1.  Tumor-Induced Osteomalacia.

Authors:  Rajiv Kumar; Andrew L Folpe; Brian P Mullan
Journal:  Transl Endocrinol Metab       Date:  2015

Review 2.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 3.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

Review 4.  Tumor-Induced Osteomalacia: an Up-to-Date Review.

Authors:  Anke H Hautmann; Matthias G Hautmann; Oliver Kölbl; Wolfgang Herr; Martin Fleck
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

5.  Successful CT guided cryoablation of phosphaturic mesenchymal tumor in the soft tissues causing tumor-induced osteomalacia: a case report.

Authors:  Sophie Cowan; Santiago A Lozano-Calderon; Raul N Uppot; Dipti Sajed; Ambrose J Huang
Journal:  Skeletal Radiol       Date:  2016-12-05       Impact factor: 2.199

6.  Successful treatment of tumor-induced osteomalacia due to an intracranial tumor by fractionated stereotactic radiotherapy.

Authors:  Valentina D Tarasova; Alejandro G Trepp-Carrasco; Robert Thompson; Robert R Recker; William H Chong; Michael T Collins; Laura A G Armas
Journal:  J Clin Endocrinol Metab       Date:  2013-09-06       Impact factor: 5.958

7.  Varied presentation of sinonasal phosphaturic mesenchymal tumour: report of a case series with follow-up.

Authors:  Regi Kurien; Vedantam Rupa; Meera Thomas
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-16       Impact factor: 2.503

Review 8.  Phosphaturic Mesenchymal Tumor: 2 New Oral Cases and Review of 53 Cases in the Head and Neck.

Authors:  Hiba Qari; Aya Hamao-Sakamoto; Clay Fuselier; Yi-Shing Lisa Cheng; Harvey Kessler; John Wright
Journal:  Head Neck Pathol       Date:  2015-11-14

9.  The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?

Authors:  Cameron K Ledford; Nicole A Zelenski; Diana M Cardona; Brian E Brigman; William C Eward
Journal:  Clin Orthop Relat Res       Date:  2013-07-19       Impact factor: 4.176

10.  Mesenchymal phosphaturic tumour: early detection of recurrence.

Authors:  Fabiana Allevi; Dimitri Rabbiosi; Marco Mandalà; Giacomo Colletti
Journal:  BMJ Case Rep       Date:  2014-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.